193 related articles for article (PubMed ID: 36927850)
1. Dynamic assessment of the double contour sign by ultrasonography helps to distinguish between gout and calcium pyrophosphate deposition disease.
Cipolletta E; Abhishek A; Di Matteo A; Grassi W; Filippucci E
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36927850
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing gouty arthritis from calcium pyrophosphate disease and other arthritides.
Löffler C; Sattler H; Peters L; Löffler U; Uppenkamp M; Bergner R
J Rheumatol; 2015 Mar; 42(3):513-20. PubMed ID: 25399385
[TBL] [Abstract][Full Text] [Related]
3. Cartilage icing and chondrocalcinosis on knee radiographs in the differentiation between gout and calcium pyrophosphate deposition.
Falkowski AL; Jacobson JA; Kalia V; Meyer NB; Gandikota G; Yosef M; Thiele RG
PLoS One; 2020; 15(4):e0231508. PubMed ID: 32298308
[TBL] [Abstract][Full Text] [Related]
4. Additive value for ultrasonographic signal in a screening algorithm for patients presenting with acute mono-/oligoarthritis in whom gout is suspected.
Lamers-Karnebeek FB; Van Riel PL; Jansen TL
Clin Rheumatol; 2014 Apr; 33(4):555-9. PubMed ID: 24510062
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound imaging for the rheumatologist. XLVII. Ultrasound of the shoulder in patients with gout and calcium pyrophosphate deposition disease.
Filippucci E; Delle Sedie A; Riente L; Di Geso L; Carli L; Ceccarelli F; Sakellariou G; Iagnocco A; Grassi W
Clin Exp Rheumatol; 2013; 31(5):659-64. PubMed ID: 24050142
[TBL] [Abstract][Full Text] [Related]
6. In patients with acute mono/oligoarthritis, a targeted ultrasound scanning protocol shows great accuracy for the diagnosis of gout and CPPD.
Cipolletta E; Filippucci E; Abhishek A; Di Battista J; Smerilli G; Di Carlo M; Silveri F; De Angelis R; Salaffi F; Grassi W; Di Matteo A
Rheumatology (Oxford); 2023 Apr; 62(4):1493-1500. PubMed ID: 35997554
[TBL] [Abstract][Full Text] [Related]
7. "Crystal clear"-sonographic assessment of gout and calcium pyrophosphate deposition disease.
Grassi W; Meenagh G; Pascual E; Filippucci E
Semin Arthritis Rheum; 2006 Dec; 36(3):197-202. PubMed ID: 17011611
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound imaging for the rheumatologist. XXV. Sonographic assessment of the knee in patients with gout and calcium pyrophosphate deposition disease.
Filippucci E; Scirè CA; Delle Sedie A; Iagnocco A; Riente L; Meenagh G; Gutierrez M; Bombardieri S; Valesini G; Montecucco C; Grassi W
Clin Exp Rheumatol; 2010; 28(1):2-5. PubMed ID: 20346230
[TBL] [Abstract][Full Text] [Related]
9. Patient-Reported Outcomes in Calcium Pyrophosphate Deposition Disease Compared to Gout and Osteoarthritis.
Whelan MG; Hayashi K; Altwies H; Tedeschi SK
J Rheumatol; 2023 Aug; 50(8):1058-1062. PubMed ID: 37061233
[TBL] [Abstract][Full Text] [Related]
10. Hyaline cartilage involvement in patients with gout and calcium pyrophosphate deposition disease. An ultrasound study.
Filippucci E; Riveros MG; Georgescu D; Salaffi F; Grassi W
Osteoarthritis Cartilage; 2009 Feb; 17(2):178-81. PubMed ID: 18657999
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and Reproducibility of Ultrasonography in Calcium Pyrophosphate Crystal Deposition in Knee Cartilage: A Cross-sectional Study.
Ottaviani S; Juge PA; Aubrun A; Palazzo E; Dieudé P
J Rheumatol; 2015 Aug; 42(8):1511-3. PubMed ID: 26077407
[TBL] [Abstract][Full Text] [Related]
12. Imaging of Crystal Disorders:: Calcium Pyrophosphate Dihydrate Crystal Deposition Disease, Calcium Hydroxyapatite Crystal Deposition Disease and Gout Pathophysiology, Imaging, and Diagnosis.
Reijnierse M; Schwabl C; Klauser A
Radiol Clin North Am; 2022 Jul; 60(4):641-656. PubMed ID: 35672096
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound for the diagnosis of gout-the value of gout lesions as defined by the Outcome Measures in Rheumatology ultrasound group.
Christiansen SN; Østergaard M; Slot O; Fana V; Terslev L
Rheumatology (Oxford); 2021 Jan; 60(1):239-249. PubMed ID: 32696059
[TBL] [Abstract][Full Text] [Related]
14. The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease.
Abhishek A; Tedeschi SK; Pascart T; Latourte A; Dalbeth N; Neogi T; Fuller A; Rosenthal A; Becce F; Bardin T; Ea HK; Filippou G; FitzGerald J; Iagnocco A; Lioté F; McCarthy GM; Ramonda R; Richette P; Sivera F; Andres M; Cipolletta E; Doherty M; Pascual E; Perez-Ruiz F; So A; Jansen TL; Kohler MJ; Stamp LK; Yinh J; Adinolfi A; Arad U; Aung T; Benillouche E; Bortoluzzi A; Dau J; Maningding E; Fang MA; Figus FA; Filippucci E; Haslett J; Janssen M; Kaldas M; Kimoto M; Leamy K; Navarro GM; Sarzi-Puttini P; Scirè C; Silvagni E; Sirotti S; Stack JR; Truong L; Xie C; Yokose C; Hendry AM; Terkeltaub R; Taylor WJ; Choi HK
Arthritis Rheumatol; 2023 Oct; 75(10):1703-1713. PubMed ID: 37494275
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and incidence of non-gout crystal arthropathy in southern Sweden.
Hameed M; Turkiewicz A; Englund M; Jacobsson L; Kapetanovic MC
Arthritis Res Ther; 2019 Dec; 21(1):291. PubMed ID: 31847885
[TBL] [Abstract][Full Text] [Related]
16. Imaging of crystalline arthropathy in 2020.
Filippucci E; Reginato AM; Thiele RG
Best Pract Res Clin Rheumatol; 2020 Dec; 34(6):101595. PubMed ID: 33012644
[TBL] [Abstract][Full Text] [Related]
17. The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease.
Abhishek A; Tedeschi SK; Pascart T; Latourte A; Dalbeth N; Neogi T; Fuller A; Rosenthal A; Becce F; Bardin T; Ea HK; Filippou G; Fitzgerald J; Iagnocco A; Lioté F; McCarthy GM; Ramonda R; Richette P; Sivera F; Andrés M; Cipolletta E; Doherty M; Pascual E; Perez-Ruiz F; So A; Jansen TL; Kohler MJ; Stamp LK; Yinh J; Adinolfi A; Arad U; Aung T; Benillouche E; Bortoluzzi A; Dau J; Maningding E; Fang MA; Figus FA; Filippucci E; Haslett J; Janssen M; Kaldas M; Kimoto M; Leamy K; Navarro GM; Sarzi-Puttini P; Scirè C; Silvagni E; Sirotti S; Stack JR; Truong L; Xie C; Yokose C; Hendry AM; Terkeltaub R; Taylor WJ; Choi HK
Ann Rheum Dis; 2023 Oct; 82(10):1248-1257. PubMed ID: 37495237
[TBL] [Abstract][Full Text] [Related]
18. Describing calcium pyrophosphate deposition: undoing the tower of Babel!
Sirotti S; Terkeltaub R; Filippou G
Curr Opin Rheumatol; 2024 May; 36(3):241-250. PubMed ID: 38517340
[TBL] [Abstract][Full Text] [Related]
19. Use of ultrasound for diagnosis and monitoring of outcomes in crystal arthropathies.
Grassi W; Okano T; Filippucci E
Curr Opin Rheumatol; 2015 Mar; 27(2):147-55. PubMed ID: 25633243
[TBL] [Abstract][Full Text] [Related]
20. The ultrasonographic pseudo-double contour sign in calcium pyrophosphate deposition disease: an anatomic explanation and how to distinguish it from gout.
Filippou G; Miguel-Pérez M; Coronel L; Sirotti S; Pacini G; Scanu A; Bong D; Möller I;
Arthritis Rheumatol; 2023 Apr; 75(4):639-640. PubMed ID: 36281790
[No Abstract] [Full Text] [Related]
[Next] [New Search]
